SWANSEA BAY UNIVERSITY HEALTH BOARD
Clinical Trials
11
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (9 trials with phase data)• Click on a phase to view related trials
Mixed Methods Study to Assess Family Members Unmet Needs in an Oncology Setting
- Conditions
- Cancer
- First Posted Date
- 2023-11-21
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Swansea Bay University Health Board
- Target Recruit Count
- 50
- Registration Number
- NCT06142071
- Locations
- 🇬🇧
South West Wales Cancer Centre, Swansea, United Kingdom
LymphAssistTM at Home (LAAH)
- Conditions
- Lymphedema ArmLymphedema of Leg
- First Posted Date
- 2022-07-13
- Last Posted Date
- 2023-10-30
- Lead Sponsor
- Swansea Bay University Health Board
- Target Recruit Count
- 40
- Registration Number
- NCT05456568
- Locations
- 🇬🇧
Swansea Bay University Health Board, Swansea, United Kingdom
The POST-ACS Study
- Conditions
- Diabetes MellitusCoronary Artery DiseaseAcute Coronary Syndrome
- First Posted Date
- 2022-04-11
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- Swansea Bay University Health Board
- Target Recruit Count
- 140
- Registration Number
- NCT05322200
- Locations
- 🇬🇧
Swansea Bay University Health Board, Swansea, United Kingdom
ExPECT: Extraperitoneal End Colostomy Trial
- Conditions
- SurgeryColostomy StomaCancer of ColonQuality of Life
- First Posted Date
- 2021-12-20
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Swansea Bay University Health Board
- Target Recruit Count
- 23
- Registration Number
- NCT05163873
- Locations
- 🇬🇧
Cardiff and Vale University Health Board, Cardiff, United Kingdom
🇬🇧Aneurin Bevan University Health Board, Newport, United Kingdom
🇬🇧Swansea Bay University Health Board, Swansea, United Kingdom
News
New Heart Failure Treatment Protocol Reduces Mortality by Nearly Two-Thirds in UK Hospitals
A new "rapid titration" protocol for heart failure treatment being implemented in UK hospitals cuts mortality by 62% and reduces rehospitalization by 30% compared to traditional approaches.